FDA Approves Biohaven's NURTEC® ODT (rimegepant) for Prevention: Now the First and Only Migraine Medication for both Acute and Preventive Treatment
Go back to FDA Approves Biohaven's NURTEC® ODT (rimegepant) for Prevention: Now the First and Only Migraine Medication for both Acute and Preventive Treatment| (NYSE: BHVN) | Delayed: 38.18 -0.54 (1.39%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $38.72 | 52 Week High | $ | |||
| Open | $38.95 | 52 Week Low | $ | |||
| Day High | $38.95 | P/E | N/A | |||
| Day Low | $36.77 | EPS | $ | |||
| Volume | 1,186,412 | |||||
| (NASDAQ: PRTG) | Delayed: 0.25 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.25 | 52 Week High | $ | |||
| Open | $0.26 | 52 Week Low | $ | |||
| Day High | $0.26 | P/E | N/A | |||
| Day Low | $0.23 | EPS | $ | |||
| Volume | 34,090 | |||||
